Tech Company Inital Public Offerings
Akebia Therapeutics IPO
Headquartered in Cambridge, Akebia Therapeutics is now a public company.
Transaction Overview
Company Name
Announced On
3/20/2014
Transaction Type
IPO
Amount
$100,300,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
245 First St. 1100
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Akebia Therapeutics is a biopharmaceutical company and global leader in developing therapies using hypoxia inducible factor (HIF) to treat serious disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Butler
Chief Financial Officer
Jason Amello
VP - Bus. Development
Karen Tubridy
VP - General Counsel
Nikki Hadas
VP - Human Resources
Tamara Dillon
VP - Operations
Michel Dahan
Browse more venture capital transactions:
Prev: 3/20/2014: ClearEdge Power venture capital transaction
Next: 3/20/2014: Getourguide venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs